{"entity":{"id":"t-cell-priming-three-signals","kind":"term","name":"T-cell priming and the three-signal model","aka":["T-cell priming","three-signal model"],"tldr":"A naive T cell's first activation depends on recognition and supporting signals. Division and killing are separate outcomes.","summary":"The three-signal teaching model groups peptide-HLA recognition by the T-cell receptor as signal one, costimulation as signal two and cytokine context as signal three. The naive cell already has its receptor. The model organises interacting processes; it is not a universal three-step checklist, and experienced or engineered cells can have different requirements.\n\nCurtsinger and colleagues showed that type I interferons or IL-12 could support naive CD8 survival and effector differentiation in defined experiments. Proliferation without a third signal did not establish cytolytic function. Antigen presentation and initial priming are different processes. In a fictional matched comparison, two cultures each divide three times but only one kills appropriate targets above target-only background: equal division does not show equal function. Compare viable-cell input, peptide loading, HLA compatibility, cell ratios, exposure and positive and negative controls. Priming does not itself demonstrate natural tumour display, tumour access, safe killing or patient benefit.","asOf":"2026-11-09","links":[{"label":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation.","url":"https://pubmed.ncbi.nlm.nih.gov/15814665/"},{"label":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.","url":"https://pubmed.ncbi.nlm.nih.gov/1847722/"},{"label":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling.","url":"https://pubmed.ncbi.nlm.nih.gov/9624004/"},{"label":"Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function.","url":"https://pubmed.ncbi.nlm.nih.gov/12732656/"}],"tags":[],"related":["t-cell"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Priming is a naive cell's initial activation in a supporting context. Signal one is TCR recognition of peptide-HLA, signal two includes CD80/CD86-CD28 costimulation and inhibitory context, and signal three includes differentiation-supporting cytokines. The receptor pre-exists the encounter. These signals interact over time; the model is not a three-button checklist and antigen-experienced or engineered cells can have different requirements.","IL-12 and type I interferons (alpha/beta) supported naive CD8 survival and cytolytic differentiation in defined experiments. Cytokines are signalling proteins, not nutritional fuel. Type I interferon can connect innate responses to priming, but this does not prescribe a universal cytokine intervention or establish every cGAS-STING step. Dendritic-cell priming support and tumour antigen display answer different questions.","Division, viable-cell expansion, cytokine production and target-cell death are distinct priming outcomes. In a fictional matched experiment both cultures show three divisions, yet only B kills appropriate targets above target-only background. Measure these outcomes separately with defined starting cells, presenting system, signal perturbation, matched time, peptide loading, HLA, cell ratios and culture conditions. Priming does not establish tumour access, natural display, safe killing or clinical benefit, and stronger stimulation can support unwanted populations.","Source scope: teaching synthesis checked against the cited abstracts and specified accessible primary text on 9 November 2026; fictional examples are not clinical observations or treatment-selection rules.","In the schematic, peptide-HLA and supporting CD80/CD86 are on the presenter, while the naive T cell has its pre-existing TCR and CD28. In the fictional culture comparison, equal division with different killing shows a functional difference without identifying its cause. Testing a proposed cytokine explanation needs a controlled change in that signal while keeping viable-cell input, target identity and exposure comparable. Positive and negative controls help distinguish biological failure from assay failure. The three-signal categories organise the investigation; a division count alone does not diagnose a missing cytokine."],"category":"Immunology"},"route":"/terms/t-cell-priming-three-signals/","neighbours":{"term":[{"id":"t-cell","kind":"term","name":"T cell","route":"/terms/t-cell/"}]}}